AIM ImmunoTech Inc. (AIM) Ownership
AIM ownership summary
as of October 17, 2026- Institutions
- 2.9% of shares outstanding
- Insiders
- 0.51% of shares outstanding
- Shares outstanding
- 39.9M
- Float
- 27.6M shares available to trade
- Short interest
- 3.54% 1.4M shares short
- Days to cover
- 0.12 short interest up 145.8% vs prior month
- Institutions 2.88%
- Insiders 0.51%
- Other investors 96.61%
AIM insider transactions
latest 18| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-04 | Thomas K Equels | Buy | $5.99 | 410 | $2,456 |
| 2025-04-04 | Peter W Rodino III | Buy | $8.99 | 5 | $45 |
| 2025-03-04 | Thomas K Equels | Buy | $11.99 | 833 | $9,988 |
| 2024-12-18 | Thomas K Equels | Buy | $20.98 | 227 | $4,762 |
| 2024-12-02 | Stewart Appelrouth | Buy | $20.98 | 111 | $2,329 |
| 2024-11-20 | Stewart Appelrouth | Buy | $18.98 | 819 | $15,545 |
| 2024-11-20 | Thomas K Equels | Buy | $17.98 | 601 | $10,806 |
| 2024-09-16 | Thomas K Equels | Buy | $29.97 | 50 | $1,498 |
| 2024-05-06 | Thomas K Equels | Buy | $40.96 | 617 | $25,272 |
| 2024-05-06 | Peter W Rodino III | Buy | $40.96 | 308 | $12,616 |
| 2024-03-21 | Nancy Bryan | Buy | $38.96 | 384 | $14,961 |
| 2024-03-15 | Peter W Rodino III | Buy | $32.97 | 378 | $12,463 |
| 2024-03-15 | Stewart Appelrouth | Buy | $32.97 | 909 | $29,970 |
| 2024-03-15 | Thomas K Equels | Buy | $32.97 | 757 | $24,958 |
| 2023-11-27 | Thomas K Equels | Buy | $43.96 | 338 | $14,858 |
| 2023-09-29 | Thomas K Equels | Buy | $43.96 | 226 | $9,935 |
| 2023-08-24 | Thomas K Equels | Buy | $66.93 | 149 | $9,973 |
| 2023-07-17 | Thomas K Equels | Buy | $58.94 | 169 | $9,961 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
AIM shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AIM
Institutional investors own 2.9% of AIM ImmunoTech's shares and insiders 0.51%. Short interest is 3.54% of the float, or 0.12 days of average trading volume. The share count rose 27,336.6% since 2014.
Related: AIM analyst forecast, AIM key metrics. See the AIM stock overview for the latest quote and news.
AIM ownership FAQ
What percentage of AIM ImmunoTech is owned by institutions?
Institutions hold 2.9% of AIM ImmunoTech's shares outstanding; insiders hold 0.51%.
What is AIM ImmunoTech's short interest?
1.4M shares of AIM ImmunoTech were sold short, 3.54% of the float; at the average daily volume it would take 0.12 days to cover.
Are insiders buying or selling AIM ImmunoTech?
Of the latest 18 reported insider transactions in AIM ImmunoTech (since July 17, 2023), 18 were purchases and 0 were sales.
How many shares of AIM ImmunoTech are outstanding?
AIM ImmunoTech has 39.9M shares outstanding, of which 27.6M are in the public float.